Please login to the form below
GSK starts trial of Nucala to seek alternate indications
Asthma therapy drug to be used to target severe nasal polyposis
Merck's anacetrapib rescued by positive phase III trial
Data suggests drug reduces MACE compared to placebo
No deal for Stada as private equity takeover bid collapses
65.52% of investors supported the takeover, just shy of the 67.5% needed to close the deal
Sanofi and Regeneron bag EU approval for arthritis drug Kevzara
The IL-6 inhibitor will be used in combination with methotrexate for adults with RA
Europe delays EMA relocation decision
Will resolve the issue in November, one month later than expected
Samsung Bioepis wins CHMP nod for second Humira biosimilar
In addition to Imraldi the regulatory advisors also backed new medicines from AbbVie and Gilead
Merck gets CHMP backing for long-delayed oral MS drug
Cladribine, which will be branded as Mavenclad, was originally rejected by the committee in 2010
Healthcare communications to journalists “on life support”
Only 2% of journalists surveyed find information provided by pharma 'trustworthy'
Smart solutions
How technology could help pharma breathe new life into branded respiratory drugs
-
Facing the new wave of biosimilarsDon’t drown out the patient voice, says advocacy group
-
Are healthcare companies delivering great customer experience?The barriers in improving customer experience in pharma
-
Alzheon says data backs potential of Alzheimer's candidateUS biotech points to new analysis of phase III results for tramiprosate
-
J+D expands its Asian reachThe UK-based group partners with Japanese consulting firm
-
CV data sets up Novartis' Ilaris for blockbuster salesDrug shown to reduce major adverse cardiovascular events
-
Shire claims FDA approval for slow-cooked ADHD drugMydayis will reach the US market in the third quarter of the year
-
GSK makes case for revaccination with ShingrixThe pharma giant seeks regulatory approval to treat people aged 50 plus
-
FDA panel backs CV claims for Novo Nordisk's VictozaLEADER trial shows the diabetes treatment reduces risk of cardiovascular death by 13%
-
Warning sounded on pharma's long-term sales prospectsAnalysts at EvaluatePharma downgrade their projections in face of pricing pressures and biosimilar competition
Latest appointments
-
New Merck Foundation appoints Rasha KelejShe takes up role as CEO of the pharma firm's newly-established non-profit
-
ThromoboGenics appoints Thomas Clay as chairman of the boardHe moves from his previous position as non-executive director
-
Dr Desiree Luthman joins Verona PharmaShe takes up its vice president position
-
Medmeme appoints Dr Joseph Laudano to medical affairs role He joins the company from Alliqua Biomedical
-
Cohn & Wolf appoints Tamsin Tierney as deputy MDShe moves to the agency from Tonic Life
Featured jobs
-
Brand Communications Manager
-
A competitive salary plus bonus
-
Director – Healthcare PR/ Policy
-
Salary TBC
-
Scientific Director
-
£70, 000 - £85, 000
-
*Design Manager*
-
Competitive Salary
-
Senior Medical Writer
-
Great salary and benefits
- Senior Account Manager – Healthcare PR
-
Salary TBC
- Senior Director, Healthcare PR, Home Counties
-
Competitive
- Account Director or Senior Account Director, Healthcare Advertis...
-
£55, 000 - £65, 000 benefits
-
Account Director - Med Comms
-
Great salary and benefits
- (Senior) Account Manager - Medical Education
-
32 - 45, 000 D.O.E
-
Principal Medical Writer
-
Great salary and benefits
- Account Manager, Healthcare PR, Global and UK
-
£33, 000 – £40, 000
- FREELANCE *Client Service/ Project Manager*
-
Competitive Salary
-
*Multi-Channel Creative Designer*
-
Competitive Salary
- Account Director - Healthcare Advertising - London
-
£50000 - £68000
- Senior Corporate Communications Manager
-
Competitive Salary
- Account Manager, Medical Communications
-
£30, 000-£40, 000
- 6-12 MONTH FREELANCE OPPORTUNITY - ACCOUNT DIRECTOR or SENIOR AC...
-
SUPERB DAY RATE AVAILABLE
-
Head of Marketing Insulin
-
Competitive Salary
Subscribe to our email news alerts
- Sanofi continues pharma's trend of ditching the corporate blog
- Alzheon says data backs potential of Alzheimer's candidate
- Samsung Bioepis wins CHMP nod for second Humira biosimilar
- CV data sets up Novartis' Ilaris for blockbuster sales
- Europe delays EMA relocation decision
- Merck gets CHMP backing for long-delayed oral MS drug
PMHub
Ashfield
Reaching your audiences, wherever they are. Ashfield is an international provider of outsourcing solutions to the pharmaceutical industry, dedicated to...
Latest intelligence
- The Devil is in the E-Detail
- All too often, pharma companies are relying on the e-detailing approach, and missing a big opportunity to engage with their customers, build relationships, and add value....
- Medical Translations: Why you need to get it right the first time
- British and American senior medical executives admit to image and reputation being at risk because of misinterpreted cultural references or linguistic errors....
- Digital disruption
- How pharma is keeping up with the pace of change...
Quick links
Infographics
